Stock Events

Arrowhead Pharmaceuticals (ARWR) Q2 2024 Earnings

9MayConfirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-1.92
-1.44
-0.95
-0.47

Details

Expected EPS
-0.471899
Actual EPS
-1.02
Surprise EPS
-0.55
Surprise Percent
+116.15%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -1.02 per share for Q2 2024.

0 Comments

Share your thoughts